Tag Archives: Health Canada

Featured Stories
Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Federal Judge Certifies Medtronic Infuse Shareholder Class Action Lawsuit

A shareholder lawsuit alleging Medtronic Inc. illegally promoted the off-label use of its Infuse bone growth product has been granted class action status by U.S. District Judge Paul Magnuson of Minnesota. According to a report from Law360.com, the Medtronic Infuse off-label promotion lawsuit was filed by several institutional investors on ...

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Do Vitamin Drinks Pose Health Risks?Do Vitamin Drinks Pose Health Risks?

Do Vitamin Drinks Pose Health Risks?

Scientists are concerned vitamin drinks are contributing to levels of vitamins and other nutrients that are not only unnecessary, but potentially harmful.

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Canadian Warning Issued for Actos Bladder Cancer Side Effect Risk

Health Canada has become the most recent national drug regulator to issue a warning about Actos and bladder cancer. Last month, the agency warned that interim results from a 10-year-study indicated that patients taking Actos for more than a year faced an increased risk of bladder cancer. Health Canada also ...

Read More

British Health Agency Strengthens Warnings about Valproate

British Health Agency Strengthens Warnings about Valproate Risk in Pregnancy

Statement issued urging healthcare professionals to give women information on birth defects when Depakote and other valproate medicines are used during pregnancy.

Read More

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

Older Patients Face Heart Attack Risk Following Surgery

Older Hip Implant, Knee Replacement Patients Face Heart Attack Risk Following Surgery

An emerging report reveals that older hip implant and knee replacement patients face increased heart attack risks following surgery. The risk for acute myocardial infarction (AMI) was seen in the first two weeks after these surgical procedures.

Read More

First Bard Avaulta Transvaginal Mesh Lawsuit Scheduled for February Trial in MDL

The first test trials in the federal C.R. Bard Avaulta transvaginal mesh litigation will most likely start next year, according to a report from Bloomberg News. About 600 lawsuits involving Bard Avaulta transvaginal mesh products are currently pending in the multidistrict litigation underway Charleston, West Virginia. U.S. District Judge Joseph ...

Read More

Stryker Recalls Metal Hip Implant Component in Canada

Stryker Recalls Metal Hip Implant Component in Canada

Stryker Orthopaedics may be facing a new wave of litigation over a recently recalled metal hip implant component. The Stryker LFIT CoCr V40 femoral heads were recalled in Canada. According to an Aug. 24, 2016 recall alert posted on Health … Continue reading

Posted in Defective Medical Devices, Metal Hip Implants | Tagged , , , , |

Health Canada Warns of Complications with IVC Filters

Health Canada Warns of Complications with IVC Filters

Health Canada has issued a safety alert regarding the use of inferior vena cava (IVC) filters, which are used to stop blood clots from reaching the heart or lungs. The regulators warned that patients receiving IVC filters have reported serious … Continue reading

Posted in Bard IVC Filter Injuries, Defective Medical Devices | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |

Health Canada Warns of Birth-Defect and Miscarriage Potential for Transplant Anti-rejection Drugs

CellCept

Canada’s health regulatory agency has issued a warning that CellCept (mycophenolate mofetil) and Myfortic (mycophenolate sodium), drugs given to prevent organ rejection in transplant patients, can cause miscarriage and congenital malformations if taken during pregnancy. The agency warns against using … Continue reading

Posted in Birth Defects, Health Concerns, Pharmaceuticals | Tagged , , , , |

Health Canada Strengthens Safety Warnings for Multiple Sclerosis Drug Gilenya

Health Canada Strengthens Safety Warnings for Drug Gilenya

Health Canada, Canada’s health regulatory agency, has updated the label information for the multiple sclerosis drug Gilenya (fingolimod) to include stronger safety warnings on the risk of skin cancer and the rare brain infection progressive multifocal leukoencephalopathy (PML), which can … Continue reading

Posted in Gilenya, Health Concerns, Pharmaceuticals | Tagged , , , , |

Health Canada Warns that Skin-Cancer Drug Zelboraf Carries Risk of Pancreatitis

Health Canada Warns Zelboraf Carries Risk of Pancreatitis

The skin-cancer drug Zelboraf (vemurafenib) is associated with a risk of pancreatitis, Health Canada warns. According to a safety alert posted on the regulator’s website Thursday, the drug’s prescribing information has been updated to reflect this risk. Zelboraf is used … Continue reading

Posted in Legal News | Tagged , , , , , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.